TCRX - Wall Street Estimates - TScan Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 2.4

-2.44 %

$ 128 M

Market Cap

-2.53

P/E

Price Target Average

400.00%

Revenue Forecast Estimate

48.78%

EBIT Estimate

23.65%

Net Income Estimate

12.22%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets TScan Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for TCRX of $12 , with forecasts ranging from a low of $12 to a high of $12 .

TCRX Lowest Price Target Wall Street Target

12 USD 400.00%

TCRX Average Price Target Wall Street Target

12 USD 400.00%

TCRX Highest Price Target Wall Street Target

12 USD 400.00%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free